1. Home
  2. VREX vs ALT Comparison

VREX vs ALT Comparison

Compare VREX & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VREX
  • ALT
  • Stock Information
  • Founded
  • VREX 2016
  • ALT 1997
  • Country
  • VREX United States
  • ALT United States
  • Employees
  • VREX N/A
  • ALT N/A
  • Industry
  • VREX Industrial Machinery/Components
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • VREX Technology
  • ALT Health Care
  • Exchange
  • VREX Nasdaq
  • ALT Nasdaq
  • Market Cap
  • VREX 443.9M
  • ALT 292.0M
  • IPO Year
  • VREX N/A
  • ALT N/A
  • Fundamental
  • Price
  • VREX $11.55
  • ALT $3.83
  • Analyst Decision
  • VREX Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • VREX 2
  • ALT 6
  • Target Price
  • VREX $19.50
  • ALT $17.40
  • AVG Volume (30 Days)
  • VREX 545.0K
  • ALT 3.0M
  • Earning Date
  • VREX 08-07-2025
  • ALT 08-12-2025
  • Dividend Yield
  • VREX N/A
  • ALT N/A
  • EPS Growth
  • VREX N/A
  • ALT N/A
  • EPS
  • VREX N/A
  • ALT N/A
  • Revenue
  • VREX $821,400,000.00
  • ALT $20,000.00
  • Revenue This Year
  • VREX $5.01
  • ALT N/A
  • Revenue Next Year
  • VREX $2.97
  • ALT $761,880.20
  • P/E Ratio
  • VREX N/A
  • ALT N/A
  • Revenue Growth
  • VREX N/A
  • ALT N/A
  • 52 Week Low
  • VREX $6.76
  • ALT $2.90
  • 52 Week High
  • VREX $16.93
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • VREX 76.25
  • ALT 51.79
  • Support Level
  • VREX $11.22
  • ALT $3.35
  • Resistance Level
  • VREX $11.51
  • ALT $3.66
  • Average True Range (ATR)
  • VREX 0.49
  • ALT 0.19
  • MACD
  • VREX 0.05
  • ALT 0.07
  • Stochastic Oscillator
  • VREX 82.53
  • ALT 86.18

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: